Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2015 | Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection | Hsu C.-S.; Liu W.-L.; Chao Y.-C.; Lin H.H.; TAI-CHUNG TSENG ; Wang C.-C.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 28 | 28 | |
2007 | Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia. | Bai, YM; Chen, JY; Yang, WS; Chi, YC; Liou, YJ; Lin, CC; Wang, YC; Lin, CY; Su, TP; Chou, P | The Journal of Clinical Psychiatry | 44 | 48 | |
2024 | Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories | Razavi-Shearer, D.; Child, H.; Razavi-Shearer, K.; Voeller, A.; Razavi, H.; Buti, M.; Tacke, F.; Terrault, N.; Zeuzem, S.; Abbas, Z.; Aghemo, A.; Akarca, U. S.; Al Masri, N.; Alalwan, A.; Blomé, M. Alanko; Jerkeman, A.; Aleman, S.; Kamal, H.; Alghamdi, A.; Alghamdi, M.; Alghamdi, S.; Al-Hamoudi, W.; Ali, E.; Aljumah, A.; Altraif, I.; Amarsanaa, J.; Asselah, T.; Baatarkhuu, O.; Babameto, A.; Ben-Ari, Z.; Berg, T.; Biondi, M.; Braga, W.; Brandão-Mello, C.; Brown, R.; Brunetto, M.; Cabezas, J.; Cardoso, M.; Martins, A.; Chan, H. L.Y.; Cheinquer, H.; Chen, C. J.; Yang, H. I.; PEI-JER CHEN ; Chien, C. H.; Chuang, W. L.; Garza, L. Cisneros; Coco, B.; Coffin, C.; Coppola, N.; Cornberg, M.; Craxi, A.; Crespo, J.; Cuko, L.; De Ledinghen, V.; Duberg, A. S.; Etzion, O.; Ferraz, M. L.; Ferreira, P.; Forns, X.; Foster, G.; Fung, J.; Gaeta, G.; García-Samaniego, J.; Genov, J.; Gheorghe, L.; Gholam, P.; Gish, R.; Glenn, J.; Hamid, S.; Hercun, J.; Hsu Y.-C.; Hu, C. C.; Huang, J. F.; Idilman, R.; Jafri, W.; Janjua, N.; Jelev, D.; Jia, J.; Kåberg, M.; Kaita, K.; JIA-HORNG KAO ; Khan, A.; Kim, D. Y.; Kondili, L.; Lagging, M.; Lampertico, P.; Lázaro, P.; Lazarus, J. V.; Lee, M. H.; Lim, Y. S.; Lobato, C.; Macedo, G.; Marinho, R.; Marotta, P.; Mendes-Correa, M. C.; Méndez-Sánchez, N.; Navas, M. C.; Ning, Q.; Örmeci, N. | Journal of hepatology | 0 | | |
2017 | Adult mortality of diseases and injuries attributable to selected metabolic, lifestyle, environmental, and infectious risk factors in Taiwan: A comparative risk assessment | Lo W.-C.; Ku C.-C.; Chiou S.-T.; CHANG-CHUAN CHAN ; CHI-LING CHEN ; Lai M.-S.; HSIEN-HO LIN | Population Health Metrics | 24 | 20 | |
2012 | Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals | CHUN-JEN LIU ; Hsu C.-S.; JIA-HORNG KAO | Journal of Internal Medicine of Taiwan | 1 | | |
2022 | Advancing the global public health agenda for NAFLD: a consensus statement | Lazarus J.V.; Mark H.E.; Anstee Q.M.; Arab J.P.; Batterham R.L.; Castera L.; Cortez-Pinto H.; Crespo J.; Cusi K.; Dirac M.A.; Francque S.; Hickman I.J.; Hocking S.L.; Hunyady B.; Idilman R.; Isakov V.A.; Jamal M.H.; Jepsen P.; Iskandar N.J.; Song M.J.; Sudhamshu K.C.; George J.; Kakizaki S.; Kalamitsis G.; Kanwal F.; JIA-HORNG KAO ; Kaplan L.; Kawaguchi T.; Khader Y.; Kim S.U.; Kodjoh N.; Koek G.; Hagström H.; Koike K.; Komas N.P.; Korenjak M.; Kugelmas M.; Labidi A.; Lange N.F.; Lavine J.E.; Lazo M.; Lee N.; Lesmana C.R.A.; Huang T.T.-K.; CHUN-JEN LIU ; Long M.T.; Lopez-Jaramillo P.; Malekzadeh R.; Mahtab M.A.; Marchesini G.; Marinho R.; Vázquez S.E.M.; Mateva L.; Nlombi C.M.; Ismail M.H.; Melin P.; Mikolasevic I.; Milovanovic T.; Musso C.; Nakajima A.; Nava E.; Nersesov A.V.; Nikolova D.; Norris S.; Novak K.; Kautz A.; Oben J.; Ong J.P.; Onyekwere C.; Papatheodoridis G.; Paruk I.; Patel K.; Macedo M.P.; Penha-Gonçalves C.; Figueroa M.P.; Hofmann W.P.; Sarin S.K.; Petta S.; de Oliveira C.P.M.S.; Puri P.; Pan C.Q.; Rac M.; Ralston J.; Ramji A.; Razavi H.; Alvares-da-Silva M.R.; Roberts S.; Loomba R.; Roden M.; Rose T.; Rouabhia S.; Rovere-Querini P.; Rowe I.A.; Sadirova S.; Salupere R.; Saparbu T.; Sayegh R.; Sebastiani G.; Miller V.; Seki Y.; Selmo J.; Serme A.K.; Shaw J.E.; Shenoy T.; Sheron N.; Shibolet O.; Silva M.; Skrypnyk I.; Socha P.; Newsome P.N.; Soriano J.; Spearman C.W.; Sridharan K.; Suárez J.J.; Sheriff D.S.; Sung K.-C.; Swain M.; Tacke F.; Taheri S.; Tan S.-S.; Ninburg M.; Tapper E.B.; Yki-Järvinen H.; Thiele M.; Shawa I.T.; Tolmane I.; Torres E.A.; Trauner M.; Treeprasertsuk S.; Turcanu A.; Valantinas J.; Ocama P.; Vesterhus M.; Waked I.; Wild S.H.; Willemse J.; Wong R.J.; Xanthakos S.; Young D.Y.; Yu M.-L.; Zheng K.I.; Zeybel M.; Ratziu V.; Zheng M.-H.; the NAFLD Consensus Consortium; Rinella M.; Romero D.; Romero-Gómez M.; Schattenberg J.M.; Tsochatzis E.A.; Valenti L.; Wong V.W.-S.; Yilmaz Y.; Younossi Z.M.; Zelber-Sagi S.; Åberg F.; Adams L.; Khatry M.S.A.; Naamani K.A.; Murillo O.A.; Allen A.M.; Alnaser F.; Alqahtani S.A.; Alswat K.; Alvaro D.; Andrade R.J.; Arrese M.; Awuku Y.A.; Ayesha M.; Baatarkhuu O.; Bakieva S.; Basu R.; Bataller R.; Bedri S.; Bosi E.; Bourliere M.; Bruha R.; Bugianesi E.; Burra P.; Buti M.; Byrne C.D.; Calleja J.L.; Carrieri P.; Carter F.; Fernandez M.I.C.; Castillo-Lopez G.; Castro-Narro G.E.; Chan H.L.Y.; Chan W.-K.; Chang Y.; Colombo M.; Coppell K.J.; Corey K.; Craxi A.; Cryer D.; Dassanayake A.; Martins A.A.S.; de Ledinghen V.; DelPrato S.; Demaio A.; Desalegn H.; Dillon J.; Duseja A.; Dorairaj P.; Ekstedt M.; El Kassas M.; Elsanousi O.M.; Esmat G.; Fan J.-G.; Farpour-Lambert N.; Flisiak R.; Fouad Y.; Fuchs M.; Gani R.A.; Gerber L.; Ghazinyan H.; Gheorghe L.; Goh G.B.-B.; Grønbæk H.; Gulnara A.; Hamid S.; Hebditch V. | Nature Reviews Gastroenterology and Hepatology | 328 | 283 | |
2013 | Adverse Events of Ribavirin Plus Pegylated Interferon Combination Therapy for Hepatitis C Patients in Taiwan: A Population-Based Study | Chu, Yu-Tseng; Liu, Chun-Jen; 郭年真 | Pharmacoepidemiol. Drug Saf. | | | |
2015 | Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota | Chou H.-H.; Chien W.-H.; Wu L.-L.; Cheng C.-H.; Chung C.-H.; Horng J.-H.; YEN-HSUAN NI ; Tseng H.-T.; Wu D.; Lu X.; HURNG-YI WANG ; PEI-JER CHEN ; Chen D.-S. | Proceedings of the National Academy of Sciences of the United States of America | 165 | 137 | |
2010 | Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link | Wang C.-C.; JIA-HORNG KAO | American Journal of Gastroenterology | 3 | 2 | |
2015 | Alcohol Use Disorder Increases the Risk of Irritable Bowel Disease A Nationwide Retrospective Cohort Study | Hsu, Tai-Yi; GUAN-YI HE ; Wang, Yu-Chiao; Chen, Chih-Yu; Wang, Shih-Hao; Chen, Wei-Kung; Kao, Chia-Hung | Medicine | 6 | 6 | |
2012 | ALISPORIVIR (ALV) PLUS PEG-INTERFERON/RIBAVIRIN (PR) IN HCV G1 TREATMENT-EXPERIENCED PATIENTS ACHIEVES PRIMARY ENDPOINT WITH SUPERIOR EFFICACY AT TREATMENT WEEK 12 COMPARED TO RETREATMENT WITH PR | Alberti, A.; Chuang, W. -L.; Flisiak, R.; Mazzella, G.; Horban, A.; Goeser, T.; Calistru, P.; Buti, M.; Davis, G.; Gong, Y.; Avila, C.; Kao, J. -H.; 高嘉宏 | J. Hepatol. | | | |
2015 | Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial | Buti M.; Flisiak R.; JIA-HORNG KAO ; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C. | Journal of Viral Hepatitis | 17 | 17 | |
2019 | ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non–small-cell lung cancer | Shaw A.T.; Solomon B.J.; Besse B.; Bauer T.M.; CHIA-CHI LIN ; Soo R.A.; Riely G.J.; Ignatius Ou S.-H.; Clancy J.S.; Li S.; Abbattista A.; Thurm H.; Satouchi M.; Camidge D.R.; Kao S.; Chiari R.; Gadgeel S.M.; Felip E.; Martini J.-F. | Journal of Clinical Oncology | 284 | 208 | |
2016 | All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study | JIA-HORNG KAO ; Lee Y.-J.; Heo J.; Ahn S.-H.; Lim Y.-S.; Peng C.-Y.; Chang T.-T.; Torbeyns A.; Hughes E.; Bhore R.; Noviello S. | Liver International | 22 | 25 | |
2014 | All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study | Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO ; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S. | The Lancet | 299 | 276 | |
1994 | Alleles Lost and Gained in Malignant Cells | PEI-JER CHEN ; Shiou-Hwei Yeh ; DING-SHINN CHEN ; Burke H.B.; Hamilton S.R.; Jen J.; Vogelstein B. | New England Journal of Medicine | 2 | 3 | |
2004 | Allelic loss of chromosome 4q21≈23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein | Shiou-Hwei Yeh ; Lin M.-W.; Lu S.-F.; Wu D.-C.; Tsai S.-F.; Tsai C.-Y.; Lai M.-Y.; Hsu H.-C.; DING-SHINN CHEN ; PEI-JER CHEN | Hepatology | 21 | 19 | |
2011 | Alpha-fetoprotein in chronic hepatitis C | Hsu C.-S.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
2011 | Alpha-Fetoprotein in Chronic Hepatitis C | HSU, CHING-SHENG; KAO, JIA-HORNG | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | | | |
2005 | Amaranthus spinosus water extract directly stimulates proliferation of B lymphocytes in vitro | BI-FONG LIN ; BOR-LUEN CHIANG ; Lin, Jin-Yuarn | International Immunopharmacology | 63 | 50 | |